INHIBITION OF E-SELECTIN-MEDIATED, ICAM-1-MEDIATED, AND VCAM-1-MEDIATED CELL-ADHESION BY BENZO[B]THIOPHENE-CARBOXAMIDES, BENZOFURAN-CARBOXAMIDES, INDOLE-, AND NAPHTHALENE-2-CARBOXAMIDES - IDENTIFICATION OF PD-144795 AS AN ANTIINFLAMMATORY AGENT
Dh. Boschelli et al., INHIBITION OF E-SELECTIN-MEDIATED, ICAM-1-MEDIATED, AND VCAM-1-MEDIATED CELL-ADHESION BY BENZO[B]THIOPHENE-CARBOXAMIDES, BENZOFURAN-CARBOXAMIDES, INDOLE-, AND NAPHTHALENE-2-CARBOXAMIDES - IDENTIFICATION OF PD-144795 AS AN ANTIINFLAMMATORY AGENT, Journal of medicinal chemistry, 38(22), 1995, pp. 4597-4614
It was previously reported that 3-alkoxybenzol[b]thiophene-2-carboxami
des exemplified by 1, 3-(1-methylethoxy)benzo[b]thiophene-2-carboxamid
e, decreased the adherence of neutrophils to activated endothelial cel
ls by inhibiting the upregulation of the adhesion molecules E-selectin
and ICAM-1 on the surface of the endothelium. This finding is extende
d here to a series of 3-thiobenzo[b]thiophene-2-carboxamides and also
heterocyclic analogs of I, including benzofurans, indoles, and naphtha
lenes. The compounds that inhibited the expression of E-selectin and I
CAM-1 had the same effect on the expression of VCAM-1. PD 144795, -3-(
1-methylethoxy)benzo[b]thiophene-2-carboxamide 1-oxide (44), the sulfo
xide analog of 1, was orally active in several models of inflammation.
The in vitro and in vivo activity of PD 144795 resided predominately
in the S-enantiomer.